Medtronic to Acquire SPR Therapeutics for $650M, Adding the Technology to Its Neuromodulation Portfolio

news.law May 26, 2026

Medtronic plc (NYSE:MDT) is one of the best robotic surgery stocks to buy. Medtronic plc (NYSE:MDT) announced on May 20 its intention to acquire SPR Therapeutics, Inc. (SPR), which is a privately held medical technology company that holds a leading position in temporary, percutaneous peripheral nerve stimulation therapies for chronic pain management.

Management stated that the transaction comprises an upfront cash payment of approximately $650 million for all the outstanding equity in SPR, and is subject to customary closing conditions and regulatory approvals.

Lakeshore Acquisition III Signs Merger Agreement with CPRO Electronics in $185M Deal

Former Girlfriend of Boy-Band Member Charged with Hiring a Hitman as Part of a Custody Dispute